T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Comscore
SCOR
$91.6M
| $14.5M | ﹤0.01% |
15,685
+800
| +5% | +$866K |
|
1202
Unum
UNM
$14.7B
| $14.4M | ﹤0.01% |
449,558
| – | – |
|
1203
Cincinnati Financial
CINF
$26.5B
| $14.4M | ﹤0.01% |
267,514
+11,305
| +4% | +$608K |
|
1204
Oil-Dri
ODC
$1.27B
| $14.3M | ﹤0.01% |
1,249,280
+1,000
| +0.1% | +$12.7K |
|
1205
Larimar Therapeutics
LRMR
$444M
| $14.3M | ﹤0.01% |
37,282
-5,351
| -13% | -$2.41M |
|
1206
Wynn Resorts
WYNN
$10.5B
| $14.3M | ﹤0.01% |
269,093
-4,434,488
| -94% | -$385M |
|
1207
G-III Apparel Group
GIII
$1.43B
| $14.3M | ﹤0.01% |
231,600
+224,000
| +2,947% | +$15.4M |
|
|
WBMD
1208
DELISTED
WebMD Health Corp.
WBMD
| $14.2M | ﹤0.01% |
356,670
+30,800
| +9% | +$1.3M |
|
|
AXON
1209
Axon Enterprise
AXON
$50B
| $14.2M | ﹤0.01% |
644,484
+240,339
| +59% | +$6.35M |
|
1210
Darden Restaurants
DRI
$25.4B
| $14.1M | ﹤0.01% |
229,715
-25,842
| -10% | -$1.64M |
|
1211
Spectrum Brands
SPB
$2.09B
| $14M | ﹤0.01% |
153,400
+42,700
| +39% | +$4.25M |
|
|
YELL
1212
DELISTED
Yellow Corporation Common Stock
YELL
| $14M | ﹤0.01% |
1,057,030
+130,360
| +14% | +$2.04M |
|
1213
Shopify
SHOP
$204B
| $14M | ﹤0.01% |
3,969,000
-44,500
| -1% | -$141K |
|
|
CTRL
1214
DELISTED
Control4 Corporation
CTRL
| $14M | ﹤0.01% |
1,711,192
-271,360
| -14% | -$2.23M |
|
1215
Goodyear
GT
$1.78B
| $14M | ﹤0.01% |
475,696
-3,790
| -0.8% | -$114K |
|
1216
Clean Harbors
CLH
$16.9B
| $13.9M | ﹤0.01% |
315,460
-79,800
| -20% | -$3.96M |
|
1217
Walker & Dunlop
WD
$1.47B
| $13.8M | ﹤0.01% |
530,433
-10
| -0% | -$250 |
|
1218
Wayfair
W
$13.9B
| $13.8M | ﹤0.01% |
393,798
-780,000
| -66% | -$29.9M |
|
|
DRII
1219
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $13.8M | ﹤0.01% |
589,300
+58,700
| +11% | +$1.62M |
|
1220
Supernus Pharmaceuticals
SUPN
$2.74B
| $13.7M | ﹤0.01% |
978,665
-95,584
| -9% | -$1.78M |
|
1221
ACI Worldwide
ACIW
$5.42B
| $13.7M | ﹤0.01% |
649,100
+140,200
| +28% | +$3.16M |
|
|
OREX
1222
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $13.7M | ﹤0.01% |
649,172
-9,198
| -1% | -$315K |
|
1223
ICU Medical
ICUI
$4.58B
| $13.6M | ﹤0.01% |
124,300
+4,200
| +3% | +$449K |
|
|
IMDZ
1224
DELISTED
Immune Design Corp.
IMDZ
| $13.6M | ﹤0.01% |
1,112,809
-15,232
| -1% | -$285K |
|
|
GAS
1225
DELISTED
AGL Resources Inc
GAS
| $13.5M | ﹤0.01% |
221,406
-2,300
| -1% | -$123K |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.